The new Pre-implantation Genetic Testing (PGT-ai 2.0 platform) enables increased confidence in the selection of euploid (ie, chromosomally normal) blastocysts for transfer in to the uterus and further reduces the risk of miscarriage. Therefore, the clinical advantage of combining IVF and PGT-ai is to produce, screen and select euploid blastocysts that can create live births.
At the Reproductive Health Group we strongly believe that only the best quality genetically tested euploid blastocysts should be transferred to shorten the time to a healthy and uneventful pregnancy.
When should Pre-implantation Genetic Testing be used?
PGT-ai is potentially suitable for anyone undergoing IVF treatment but may be of particular benefit in the following scenarios:
- For women over the age of 35
- In cases where there have been several failed cycles of IVF already (recurrent implantation failure) or recurrent miscarriages
- Where there is a known family history of chromosomal problems
- The male partner’s sperm has been identified as containing a high number of chromosomal abnormalities.
Talk to us about PGT-ai
If you would like to learn more about PGT-ai, please call us on 01925 202180 or contact us online here.